Alloway Paul 4
4 · Homology Medicines, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Alloway Paul
See Remarks
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-01-01−4,290→ 4,420 total→ Common Stock (4,290 underlying) - Exercise/Conversion
Common Stock
2023-01-01+4,290→ 17,913 total - Exercise/Conversion
Restricted Stock Units
2023-01-01−5,280→ 10,720 total→ Common Stock (5,280 underlying) - Exercise/Conversion
Common Stock
2023-01-01+5,280→ 23,193 total
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]Includes 3,397 shares acquired under Issuer's Employee Stock Purchase Plan on February 28, 2022.
- [F3]The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one half of the RSUs on each of January 1, 2023 and January 1, 2024. The RSUs do not have an expiration date.
- [F4]The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.